Literature DB >> 6088630

Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.

J E Merrill, C Mohlstrom, C Uittenbogaart, V Kermaniarab, G W Ellison, L W Myers.   

Abstract

In an effort to further characterize the defective proliferative response of T lymphocytes to mitogens in multiple sclerosis (MS) patients, we examined the response to and production of interleukin 2 (IL 2) by both peripheral blood lymphocytes (PBL) and cerebrospinal fluid mononuclear cells. We also examined the proportion of cells bearing receptors for IL 2 and transferrin. Chronic progressive MS patients have an abnormally low response to exogenous IL 2 as compared to controls. Whereas acute relapse patients' PBL demonstrated a normal IL 2 response during an exacerbation, they showed reduced responsiveness during remission. These abnormalities could not be explained by different dose or kinetic response optima to PHA or IL 2, nor could they be explained by depressed numbers of IL 2 or transferrin receptor-bearing lymphocytes. Production of IL 2 by PBL was also abnormal in MS patients. Chronic progressive patients produced elevated levels of IL 2, whereas acute relapse patients undergoing an exacerbation produced diminished levels of IL 2. During remission, these levels returned to that of controls'. The effect of 1200 rad x-irradiation or nylon wool removal of adherent cells was a significantly greater augmentation of IL 2 production in MS patients than in other neurologic disease or normal controls. Cerebrospinal fluid lymphocytes from MS patients had normal proportions of IL 2 receptor-bearing cells, but were deficient in their IL 2 response and production as compared to autochthonous or control PBL. The inability of some MS patients' lymphocytes to clonally expand in response to IL 2 might contribute to the pathogenicity of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088630

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis.

Authors:  Xiaojun Wu; Weihong Pan; Yi He; Hung Hsuchou; Abba J Kastin
Journal:  J Neuroimmunol       Date:  2010-04-28       Impact factor: 3.478

2.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  Abnormal differentiation of immunoregulatory T-lymphocyte subpopulations in the major histocompatibility complex (MHC) class II antigen deficiency syndrome.

Authors:  L T Clement; J V Giorgi; S Plaeger-Marshall; A Haas; E R Stiehm; A M Martin
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

4.  Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.

Authors:  S Inogés; J Merino; E Bandrés; P De Castro; M L Subirá; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

Authors:  J C Craig; S A Hawkins; M W Swallow; J A Lyttle; V H Patterson; J D Merrett; M Haire
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  Human natural killer (NK) cells produce a late-acting B-cell differentiation activity.

Authors:  H Kimata; E H Sherr; A Saxon
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

7.  Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  D Donati; P Annunziata; G C Guazzi; D Boraschi; A Tagliabue
Journal:  Ital J Neurol Sci       Date:  1990-02

8.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  Selective loss of a subset of T helper cells in active multiple sclerosis.

Authors:  L M Rose; A H Ginsberg; T L Rothstein; J A Ledbetter; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.

Authors:  N Miyasaka; N Murota; K Yamaoka; K Sato; T Yamada; T Nishido; M Okuda
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.